NHS saving extra £1.3bn from generic drugs
The National Health Service in England and Wales saved an extra £1.3 billion last year as usage of...
Read moreEU approves Novartis glaucoma combo
Patients with glaucoma in Europe can now get access to Novartis' Simbrinza (brin...
Read moreGlaxoSmithKline's China crisis has spooked shareholders
Investigation of drug firm's sales practices underline perils to all British companies of entering...
Read moreToo much intervention makes patients sicker
A culture of over-investigation and over-treatment is now one of the greatest threats to western...
Read moreMillions unnecessarily labelled pre-diabetic, health experts say
Diagnosis increases likelihood of being prescribed medicine that merely delays onset of illness,...
Read moreAbbVie's raised proposal for Shire gets board backing
Board of London-listed drug company in 'detailed discussions' with US pharmaceutical firm A...
Read moreChina charges GSK foreign consultants with illegal investigation
Briton Peter Humphrey and his US wife charged with illegally obtaining private data on Chinese...
Read moreNew pharmaceutical conduct code under fire for not going far enough
Health forum says doctors will still not be deterred from accepting money which could influence...
Read moreNovartis reinforces its leadership in research with new global guidelines for Investigator Initiated Trials (IITs)
Novartis released today new global guidelines for Investigator Initiated Trials (IITs).
Read moreDrug shows promise for effectively treating metabolic syndrome
University of Utah researchers have discovered that an enzyme involved in intracellular signaling...
Read more



